Effect of pharmaceutical care on blood pressure control and health-related quality of life in patients with resistant hypertension

dc.creatorDe Souza, WA
dc.creatorYugar-Toledo, JC
dc.creatorBergsten-Mendes, G
dc.creatorSabha, M
dc.creatorMoreno, H
dc.date2007
dc.dateSEP 15
dc.date2014-11-17T16:56:01Z
dc.date2015-11-26T16:44:59Z
dc.date2014-11-17T16:56:01Z
dc.date2015-11-26T16:44:59Z
dc.date.accessioned2018-03-28T23:30:31Z
dc.date.available2018-03-28T23:30:31Z
dc.identifierAmerican Journal Of Health-system Pharmacy. Amer Soc Health-system Pharmacists, v. 64, n. 18, n. 1955, n. 1961, 2007.
dc.identifier1079-2082
dc.identifierWOS:000249768000019
dc.identifier10.2146/ajhp060547
dc.identifierhttp://www.repositorio.unicamp.br/jspui/handle/REPOSIP/64398
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/64398
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/64398
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1274092
dc.descriptionPurpose. Verification of whether pharmacotherapeutic follow-up improves arterial blood pressure (BP) was conducted, and whether this improvement alters the quality of life of patients with resistant hypertension in a university teaching hospital in Brazil was determined. Methods. A prospective survey of 44 patients was carried out over a period of 20 months. Each patient was followed up for 12 months. Pharmaceutical care was assessed using the following methods: measurement of the office BP and ambulatory BP monitoring, adherence to therapy, drug-related problems, and the use of health care facilities (urgent care visits and hospital admissions). The health-related quality of life (HRQOL) of patients was also assessed using the 36-Item Short Form Health Survey (SF-36) questionnaire and a physical symptoms profile. Results. The majority (95.5%) of patients adhered to the treatment throughout the study, and there was a significant reduction in BP (p < 0.05). Nearly all of the domains of HRQOL assessed by SF-36 remained unchanged during the follow-up except for a significant improvement in social functioning (p = 0.041). There was a significant reduction in moderate and severe physical symptoms (p = 0.005). There were also significant reductions in the number of urgent care visits (p = 0.0001) and hospital admissions (p = 0.006). Conclusion. The pharmaceutical care provided by a pharmacist in an ambulatory care clinic in Brazil improved BP, adherence to anti hypertensive medications, and the social functioning of patients with resistant hypertension.
dc.description64
dc.description18
dc.description1955
dc.description1961
dc.languageen
dc.publisherAmer Soc Health-system Pharmacists
dc.publisherBethesda
dc.publisherEUA
dc.relationAmerican Journal Of Health-system Pharmacy
dc.relationAm. J. Health-Syst. Pharm.
dc.rightsfechado
dc.sourceWeb of Science
dc.subjectambulatory care
dc.subjectcompliance
dc.subjectdata collection
dc.subjecthospitals
dc.subjecthypertension
dc.subjectinterventions
dc.subjectpatients
dc.subjectpharmaceutical care
dc.subjectpharmacists
dc.subjectquality of life
dc.subjecttoxicity
dc.subjectSurvey Sf-36
dc.subjectPharmacists
dc.subjectInterventions
dc.subjectManagement
dc.titleEffect of pharmaceutical care on blood pressure control and health-related quality of life in patients with resistant hypertension
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución